Citation: Kt. Godder et Pj. Henslee-downey, Colony-stimulating factors in stem cell transplantation: Effect on qualityof life, J HEMATH ST, 10(2), 2001, pp. 215-228
Authors:
Lamb, LS
Musk, P
Ye, Z
van Rhee, F
Geier, SS
Tong, JJ
King, KM
Henslee-Downey, PJ
Citation: Ls. Lamb et al., Human gamma delta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response, BONE MAR TR, 27(6), 2001, pp. 601-606
Authors:
Chiang, KY
Van Rhee, F
Godder, K
Bridges, K
Adams, S
Mehta, J
Henslee-Downey, PJ
Citation: Ky. Chiang et al., Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia, BONE MAR TR, 27(5), 2001, pp. 507-510
Authors:
Godder, KT
Hazlett, LJ
Abhyankar, SH
Chiang, KY
Christiansen, NP
Bridges, KD
Lee, CG
Geier, SS
Goon-Johnson, KS
Gee, AP
Pati, AR
Parrish, RS
Henslee-Downey, PJ
Citation: Kt. Godder et al., Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: Younger donors and absence of peripheral blasts improve outcome, J CL ONCOL, 18(9), 2000, pp. 1856-1866
Authors:
Davies, SM
Ramsay, NKC
Klein, JP
Weisdorf, DJ
Bolwell, B
Cahn, JY
Camitta, BM
Gale, RP
Giralt, S
Heilmann, C
Henslee-Downey, PJ
Herzig, RH
Hutchinson, R
Keating, A
Lazarus, HM
Milone, GA
Neudorf, S
Perez, WS
Powles, RL
Prentice, HG
Schiller, G
Socie, G
Vowels, M
Wiley, J
Yeager, A
Horowitz, MM
Citation: Sm. Davies et al., Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J CL ONCOL, 18(2), 2000, pp. 340-347
Authors:
DeRienzo, SY
Chiang, KY
O'Neal, WM
Godder, K
Abhyankar, S
Christiansen, NP
Bridges, KD
Henslee-Downey, PJ
Citation: Sy. Derienzo et al., Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrowtransplantation, PHARMACOTHE, 20(10), 2000, pp. 1175-1178
Authors:
Singhal, S
Safdar, A
Chiang, KY
Godder, K
van Rhee, F
Garner, F
Foster, B
Dubovsky, D
Henslee-Downey, PJ
Mehta, J
Citation: S. Singhal et al., Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosis, BONE MAR TR, 26(11), 2000, pp. 1231-1233
Authors:
Champlin, RE
Passweg, JR
Zhang, MJ
Rowlings, PA
Pelz, CJ
Atkinson, KA
Barrett, AJ
Cahn, JY
Drobyski, WR
Gale, RP
Goldman, JM
Gratwohl, A
Gordon-Smith, EC
Henslee-Downey, PJ
Herzig, RH
Klein, JP
Marmont, AM
O'Reilly, RJ
Ringden, O
Slavin, S
Sobocinski, KA
Speck, B
Weiner, RS
Horowitz, MM
Citation: Re. Champlin et al., T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities, BLOOD, 95(12), 2000, pp. 3996-4003
Authors:
Lamb, LS
Gee, AP
Hazlett, LJ
Musk, P
Parrish, RS
O'Hanlon, TP
Geier, SS
Folk, RS
Harris, WG
McPherson, K
Lee, C
Henslee-Downey, PJ
Citation: Ls. Lamb et al., Influence of T cell depletion method on circulating gamma delta T cell reconstitution and potential role in the graft versus leukemia effect. (vol 1,pg 7, 1999), CYTOTHERAPY, 1(4), 1999, pp. 360-360
Authors:
Lamb, LS
Gee, AP
Hazlett, LJ
Musk, P
Parrish, RS
O'Hanlon, TP
Geier, SS
Folk, RS
Harris, WG
McPherson, K
Lee, C
Henslee-Downey, PJ
Citation: Ls. Lamb et al., Influence of T cell depletion method on circulating gamma delta T cell reconstitution and potential role in the graft-versus-leukemia effect, CYTOTHERAPY, 1(1), 1999, pp. 7-19
Citation: Pj. Henslee-downey et E. Gluckman, Allogeneic transplantation from donors other than HLA-identical siblings, HEMAT ONCOL, 13(5), 1999, pp. 1017
Citation: Rs. Parrish et al., A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation, STAT MED, 18(4), 1999, pp. 423-440
Authors:
Lamb, LS
Abhyankar, SA
Hazlett, L
O'Neal, W
Folk, RS
Vogt, S
Parrish, RS
Bridges, K
Henslee-Downey, PJ
Gee, AP
Citation: Ls. Lamb et al., Expression of CD134 (0X-40) on T cells during the first 100 days followingallogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease, CYTOMETRY, 38(5), 1999, pp. 238-243